Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Cosomil, Inc. logo — Developing cutting-edge blood-based diagnostics using our gr...

Cosomil, Inc.

Developing cutting-edge blood-based diagnostics using our groundbreaking Single Enzyme Activity-based Liquid Biopsy.

Founded 2022 Japan Japan 4 employees Seed Biotechnology, Health Care +1

General Information

Company Name Cosomil, Inc.
Founded Year 2022
Location Japan Japan
Employees 4
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Cosomil, Inc.. To contact Cosomil, Inc., visit cosomil.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cosomil, Inc. compare?

A PDF of Cosomil, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cosomil, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cosomil, Inc.

Cosomil, Inc. is a Japanese startup founded in 2022, specializing in the development of cutting-edge blood-based diagnostics using their groundbreaking Single Enzyme Activity-based Liquid Biopsy. The company's slogan "Developing cutting-edge blood-based diagnostics using our groundbreaking Single Enzyme Activity-based Liquid Biopsy" reflects its commitment to advancing early cancer detection. With a focus on Biotechnology, Health Care, and Pharmaceutical industries, Cosomil, Inc. has garnered attention for its innovative approach to cancer diagnostics. The company recently secured a Seed Round investment on 29 November 2023 with significant backing from ANRI, Coral Capital, and Green Core. The company's proprietary technology, known as Single Enzyme Activity-based Protein Profiling, enables ultra-sensitive detection of enzyme activity at the single molecule level using state-of-the-art fluorescent probes and microdevices, positioning Cosomil, Inc. as a promising player in the field of early disease diagnosis.

Business keywords: Liquid Biopsy, Cancer Detection, Blood-based Diagnostics, Enzyme Activity, Protein Profiling, Fluorescent Probes, Microdevices, Early Diagnosis, Medical Technology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 3
ANRI Coral Capital Green Core
ANRI, Coral Capital +1
29 Nov 2023

Cosomil, Inc. Alternatives & Competitors

View All Alternatives
Cosomil, Inc. vs
Amadix
Amadix Spain

Early cancer detection in blood

Grant
43 employees
Biopharma, Biotechnology
Cosomil, Inc. vs
Savicell
Savicell Israel

THE IMMUNOBIOPSY™ COMPANY – BECAUSE EARLY DETECTION IS LIFE™

7 employees
Biotechnology, Health Care
Cosomil, Inc. vs
Lucence
Lucence United States

Overcoming cancer through earlier detection

Series A
101 employees
Biotechnology, Health Care
Also compare with: Cosomil, Inc. vs Adela, Inc. Adela, Inc. View all alternatives

FAQ About Cosomil, Inc.

Developing cutting-edge blood-based diagnostics using our groundbreaking Single Enzyme Activity-based Liquid Biopsy.
Cosomil, Inc. was founded in 2022.
Cosomil, Inc. is headquartered in Japan.
Cosomil, Inc. operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Liquid Biopsy, Cancer Detection, Blood-based Diagnostics and Enzyme Activity.
Cosomil, Inc. has approximately 4 employees.
Cosomil, Inc. has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Cosomil, Inc. include Amadix, Savicell, Lucence, Dxcover, Adela, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cosomil, Inc. and Amadix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cosomil, Inc., https://bouncewatch.com/company/cosomil-inc, updated 24 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout